Increased use of hypnotics in individuals with celiac disease: a nationwide case-control study

BMC Gastroenterology

Table 4 Risk of poor sleep starting more than 1 year before celiac disease diagnosis

	Celiac disease n = 1086 (%)	Controls n = 5382 (%)	Odds ratio	95% CI
Poor sleep ^a	49 (4.5)	200 (3.7)	1.23	0.88-1.71
Type of hypnotics used ^b
Benzodiazepine-related drugs	40 (3.7)	151 (2.8)	1.32	0.92-1.90
Benzodiazepines	7 (0.6)	20 (0.4)	1.70	0.73-3.81
Other hypnotics	5 (0.5)	51 (0.9)	0.49	0.20-1.23
Melatonin receptor agonists^c	-	-	-	-

^aPoor sleep defined as ≥2 prescriptions of hypnotics before celiac disease diagnosis. Data capture of hypnotics: July 1st 2006-January 29th 2008.
^bSee Additional file 1: Table S1 for anatomical therapeutic chemical (ATC) codes used to classify hypnotics.
^cDue to lack of events no odds ratio was estimated.

ISSN: 1471-230X